Skip to content
Search

Latest Stories

Reliance launches JioMeet to take on Zoom

INDIA's Reliance has launched JioMeet video conferencing app with unlimited free calling facility and starts a rate war on rival Zoom. It is available across Android, iOS, Windows, macOS and web, the company said.

JioMeet supports HD audio and video call quality with up to 100 participants and offers features like screen sharing, meeting schedule feature and more. Unlike Zoom, it does not impose a 40-minute time limit. Calls can go on as long as 24 hours, and all meetings are encrypted and password-protected, the company said.


While Reliance provides the facility for free, Zoom charges $15 per month ($180 per year)for meetings of more than 40 minutes.

According to details given on the website, JioMeet offers easy sign up with either mobile number or e-mail ID and allows creation of instant meeting. The meeting in HD audio and video quality can be scheduled in advance and details shared with invitees.

Each meeting is password protected and the host can enable 'Waiting Room' to ensure no participant joins without permission. It also allows creation of groups and starting calling/chatting on a single click.

The app has already seen more than 500,000 downloads on the Google Play Store and iOS. It should be noted that India recently banned 59 popular Chinese apps including TikTok on grounds that they threatened national security and data privacy.

JioMeet app allows national and international seminars as well as hosting of cultural and social events. Unlike Zoom, JioMeet users can switch from one device to another without dropping out of the call. It allows nine active participants on a single mobile screen whereas Zoom allows only four.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less